Bougainville Cooperating with BCSC Review
VANCOUVER, British Columbia, Feb. 07, 2019 (GLOBE NEWSWIRE) — Bougainville Ventures Inc. (“Bougainville” or the “Company”) announces that it has received inquiries from the British Columbia Securities Commission (“BCSC”) with respect to its transaction (“Transaction”) involving Gene Bank Research Inc. (see news release dated November 1, 2018). The Company is cooperating fully with the BCSC, and does not expect that the inquiries will interfere with the Company’s day-to-day activities. The Company is also reviewing the substance of the Transaction and working with legal counsel to determine its next steps.
The Company notes that it had requested a voluntary trading halt pending dissemination of this news release.
About Bougainville Ventures, Inc.
Bougainville provides cannabis infrastructure and seed-to-sale services to I-502 tenant-growers leasing greenhouse facilities space and providing fully built-out, turnkey solutions and ancillary services including processing, cannabis expertise and marketing and sales resources. Greenhouse canopies provide a 50% saving in cultivation cost.
For more information please visit: http://bougainvilleinc.com/
On behalf of the Board of Directors
BOUGAINVILLE VENTURES INC.
Andy Jagpal, CEO and Director
For further information, please contact Andy Jagpal at [email protected] or 1-844-734-8420
FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
No regulatory authority has approved or disapproved the information contained in this news release.